In diabetes, the activation of NLRP3 inflammasome machinery in macrophages promotes inflammation and NETosis, in turn, NETs contribute to a self-perpetuating cycle of enhanced IL-1β and IL-18 production, leading to accumulation of NETs and inflammatory mediators in wound site and impair wound healing. Here, IL1B is linked to diabetes mellitus.